Table 18.
Compound | Type of test | Experimental system | Exposure conditions | Result | Comments | Reference |
---|---|---|---|---|---|---|
C23, 43% chlorination | Reverse mutation assay | S. TyphimuriumTA 97, TA 98, TA 100, TA 1535 | Up to 10,000 μg/plate+/− S9 (rat and hamster liver) | Negative |
|
NTP (1986b) |
Cereclor 42(C20–30, 42% chlorination) | Reverse mutation assay | S. TyphimuriumTA 98, TA 100, TA 1535, TA 1538 | Up to 2,500 μg/plate+/− S9 (rat liver)Neg. control: DMSOPos. control: 1,3‐propanesultone and 2AA | Negative |
|
Birtley et al. (1980) |
C23, 43% chlorination | Chromosomal aberration test | Chinese hamster ovary cells | −S9:First experiment: 0, 1,250, 2,500, 5,000 μg/mL Exposure: 8 h, harvesting: 2–2.5 h laterSecond experiment: 0, 3,784, 4,400, 5,000 μg/mL+S9 (rat liver):0, 2.513, 3,750, 5,000 μg/mLExposure: 2 h, harvesting: 8–10 h laterNeg. control: acetonePos. control: −S9: MMC, +S9: cyclophosphamide |
−S9:First experiment:Significant increase at 5,000 μg/mL, no concentration response relationshipSecond experiment:Significant increase at 5,000 μg/mL, clear concentration response relationship+S9:No increase CA Positive without metabolic activation |
Cytotoxicity not reported,Oily droplets formed at doses > 157 μg/mL | Anderson et al. (1990) |
C23, 43% chlorination | SCE | Chinese hamster ovary cells | −S9:First experiment: 0, 0.5, 5.0, 5,000 μg/mL,Second experiment:0, 5.0, 1,700 and 5,000 μg/mL+S9 (rat liver):0, 5.0, 500, 1,700 and 5,000 μg/mL |
First experiment:−S9:Significant increase at 5,000 μg/mL, concentration response relationshipSecond experiment:Significant increase at all three concentrations, concentration response relationship+S9:Significant increase at all four concentrations, concentration response relationship up to 500 μg/mL, at the two highest concentrations induction of SCE was lower than at 500 μg/mL Positive |
Cytotoxicity not reported | Anderson et al. (1990) |
C22–26, 43% chlorination | In vivoChromosomal aberrationBone‐marrow cells | Male F344 rats | 8 animals/groupGavage, daily for 5 days0, 500, 1,500 or 5,000 mg/kg bw per dayNegative control: corn oil. Positive control: cyclophosphamide |
No signs of toxicityNo increased frequency of chromosomal aberrations, excluding gaps detected in samples taken at day 6 Negative |
|
IRDC (1983i)Unpublished study, see Documentation provided to EFSA |
C20–30, 70% chlorination | In vivo Chromosomal aberration Bone‐marrow cells | F344 rats | 8 animals/groupGavage, daily for 5 days0, 500, 1,500 or 5,000 mg/kg bw per day |
bw gain decreased in high‐dose animalsNo increased frequency of chromosomal aberrations Negative |
Cytotoxicity not reported and therefore, no indication of whether or not the test substance reached the bone marrow | IRDC (1983, as cited by WHO/IPCS, 1996) |
bw: body weight; SCE: sister chromatid exchange.